Achieve Life Sciences, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -118.2% | -118.2% | -69.8% |
| FY2022 | -510.1% | -510.1% | -141.3% |
| FY2023 | 2,059.0% | 2,059.0% | -153.9% |
| FY2024 | -190.6% | -190.6% | -103.1% |
| FY2025 | -254.0% | -254.0% | -130.8% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -118.2% | -118.2% | -69.8% |
| FY2022 | -510.1% | -510.1% | -141.3% |
| FY2023 | 2,059.0% | 2,059.0% | -153.9% |
| FY2024 | -190.6% | -190.6% | -103.1% |
| FY2025 | -254.0% | -254.0% | -130.8% |